Solid cancers after allogeneic hematopoietic cell transplantationJ. Douglas Rizzo, H. Joachim Deeg, Rochelle E. Curtis et al.|Blood|2008Cited by 489
Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantationOla Landgren, Rochelle E. Curtis, Ethel S. Gilbert et al.|Blood|2009Cited by 400
Recommended Screening and Preventive Practices for Long-Term Survivors after Hematopoietic Cell TransplantationNavneet S. Majhail, André Tichelli, John R. Wingard et al.|Biology of Blood and Marrow Transplantation|2011Cited by 363
Real-World Data Showing Trends and Outcomes by Race and Ethnicity in Allogeneic Hematopoietic Cell Transplantation: A Report from the Center for International Blood and Marrow Transplant ResearchJeffery J. Auletta, Bronwen E. Shaw, Jianqun Kou et al.|Transplantation and Cellular Therapy|2023Cited by 68
Related peripheral blood stem cell donors experience more severe symptoms and less complete recovery at one year compared to unrelated donorsMichael A. Pulsipher, Thomas R. Spitzer, Brent R. Logan et al.|Haematologica|2018Cited by 22